Literature DB >> 7843766

Production of aldosterone in isolated rat blood vessels.

Y Takeda1, I Miyamori, T Yoneda, K Iki, H Hatakeyama, I A Blair, F Y Hsieh, R Takeda.   

Abstract

Angiotensin I (Ang I), Ang II, angiotensinogen, and renin are formed locally in the vasculature. We undertook this study to determine whether the rat mesenteric artery produces aldosterone and to investigate the effects of adrenalectomy, an angiotensin-converting enzyme inhibitor, Ang II, or potassium on aldosterone production in vascular tissue. Isolated rat mesenteric arteries were perfused with Krebs-Ringer solution for 4 hours. The perfusate was collected and chromatographed in a reversed-phase high-performance liquid chromatographic (HPLC) system. The fraction corresponding to synthetic aldosterone was collected and analyzed by mass spectrometry. The aldosterone concentration in the perfusate from the adrenalectomized rats and rats treated with an angiotensin-converting enzyme inhibitor was measured using radioimmunoassay after HPLC separation. The mass spectra of synthetic aldosterone and aldosterone isolated from the perfusate of rat mesenteric arteries were identical. Aldosterone production in the mesenteric arteries of adrenalectomized rats was increased and of rats treated with an angiotensin-converting enzyme inhibitor was reduced compared with that of controls. Ang II (1.9 x 10(10) mol/L) and potassium (6.0 mmol/L) increased aldosterone production in mesenteric arteries. This study shows that the rat mesenteric artery produces aldosterone and that the intravascular renin-angiotensin-aldosterone system may contribute to vascular tone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843766     DOI: 10.1161/01.hyp.25.2.170

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Converging indications of aldosterone antagonists (spironolactone and eplerenone): a narrative review of safety profiles.

Authors:  Mohammed I Danjuma; Ipshita Mukherjee; Janine Makaronidis; Serge Osula
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 3.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

Review 4.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

5.  Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.

Authors:  Matthew Fomonyuy Yuyun; Sandeep K Jutla; Paulene A Quinn; Leong L Ng
Journal:  Heart Asia       Date:  2012-08-24

Review 6.  Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

7.  Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways.

Authors:  Alexander W Krug; Lena Allenhöfer; Robert Monticone; Gaia Spinetti; Michael Gekle; Mingyi Wang; Edward G Lakatta
Journal:  Hypertension       Date:  2010-04-26       Impact factor: 10.190

8.  Aldosterone-receptor antagonism and end-stage renal disease.

Authors:  Niall McLaughlin; Todd W B Gehr; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 9.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

10.  Endothelial cell swelling by aldosterone.

Authors:  H Oberleithner; S W Schneider; L Albermann; U Hillebrand; T Ludwig; C Riethmüller; V Shahin; C Schäfer; H Schillers
Journal:  J Membr Biol       Date:  2003-12-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.